There are 3164 resources available
LBA71 - Open-label, multicentre randomised trial of Radium223-docetaxel versus docetaxel-Radium223 sequence in metastatic castration resistant prostate cancer (mCRPC) with prospective biomarker evaluation (RAPSON study)
Presenter: Vincenza Conteduca
Session: Mini oral session: GU tumours, prostate
Resources:
Abstract
Slides
Webcast
Discussion
Session: Multidisciplinary team working in the management of anal cancer: Current perspectives
Resources:
Webcast
Q&A and discussion
Session: Cancer neuroscience in brain tumours and beyond
Resources:
Webcast
Q&A and discussion
Session: ESMO-EONS collaborative session: Caring for the carers
Resources:
Webcast
LBA13 - Adjuvant ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in patients (Pts) with HR+/HER2− early breast cancer (EBC): 4-year outcomes from the NATALEE trial
Presenter: Peter A. Fasching
Session: Proffered paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
998MO - Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT study
Presenter: Oliver Klein
Session: Mini oral session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA70 and LBA71
Presenter: Deborah Mukherji
Session: Mini oral session: GU tumours, prostate
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Frank Winkler
Session: Cancer neuroscience in brain tumours and beyond
Resources:
Webcast
Q&A and discussion
Session: eHealth and digital innovations
Resources:
Webcast
1597MO - Clinical activity of BMS-986365 (CC-94676), a dual androgen receptor (AR) ligand-directed degrader and antagonist, in heavily pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Dana Rathkopf
Session: Mini oral session: GU tumours, prostate
Resources:
Abstract
Slides
Webcast